All right, everybody, we should get started. We're five after the hour. So, welcome. Okay, thank you all for coming here.

We're going to be talking about how to think critically about he and hemalignancy studies. And I want to introduce a few people. So, of course, you know me and Aaron. So I'm Vinay Prasad. I'm a professor at UCSF. I take care of

everything, every week in clinic at the general hospital. That's everything from benign hematology

von Villabrands, iron deficiency to ET, MDS, Hodgkins, non-Hodgkins. It's kind of like a county

hospital. We've got to see everything. And I also do some solid tumor too, some people may know. And I'm joined by Aaron Goodman, who is also known as

Papa Heem. And this is his hometown of San Diego, and he's been showing us all the great

taco stands. And Aaron is, of course, associate professor at UCSD. He is a heem malignancy expert,

and he is a transplanter, which means, and he is a transplanter, which means he knows

you need a transplant. If you have intermediate risk AML, you definitely need that aloe

transplant, and he's going to talk about that and other fun topics today. And we're also joined by a

special guest. Oh my God, how did he get up there? This is Moni. Yeah, did you, that's why I was

smiling it earlier. Mani Moeudine, assistant professor at Huntsman University of Utah. And he's

going to hold our feet to the fire for everything, myeloma, but we also got Raj too. So we got

a lot of people. This is a tough audience. If we say anything wrong, we're going to get in trouble up here.

So before I really get started, though, I'm curious about all of you. So what's your backgrounds? Okay, I'm going to give a few categories and if it applies to you, maybe put your hand up. Okay, so I know there's a few people here from industry. Is that the case? Anyone from industry? Okay, great. Thank you so much for coming. We'll take it easy on you all.

Is anyone here from insurers or PBMs or other, okay?

Anyone here who works as a mid-level or a nurse or a nurse practitioner or PA?

Anybody who is in oncology or, sorry, hematology attending?

Hymetendings, okay.

And people who are hem, fellows.

Okay, and any residents?

A couple.

...